Commentary

Podcast

Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value

Author(s):

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.

On this episode of Managed Care Cast, we're talking with Jason Shafrin, PhD, the senior managing director of FTI Consulting's Center for Healthcare Economics and Policy and an adjunct professor in the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences.

His study, "Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy," estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment from a survey of individuals planning to have children.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Susan Sabo-Wagner, MSN, RN, OCN.
Screenshot of Scott Soefje, PharmD, BCOP, during a video interview with. the AJMCtv logo in the top corner
Michael Lynch, MD, UPMC
Sophia Humphreys, PharmD, MHA, BCBBS
Ticiana Leal, MD, Emory Winship Cancer Institute
dr ian neeland
Javed Butler, MD
Neil Goldfarb, Greater Philadelphia Business Coalition on Health
dr manisha jhamb
Martin Kolb, MD, PhD, professor of medicine at McMaster University
Related Content
Enhanced image of leukemia | Image Credit: © freshidea - stock.adobe.com
September 6th 2024

Two Leukemia Stem Cell Subtypes Identified

Karen Jacobson-Sive
Researchers have discovered 2 leukemia stem cell subtypes with distinct epigenetic and transcriptional signatures.
Combatting the Opioid Epidemic: Insights From the Front Lines
September 2nd 2024

Combatting the Opioid Epidemic: Insights From the Front Lines

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
A combination of infrared spectroscopy and AI could benefit the diagnosis of patients with MG | image credit: Tori Art - stock.adobe.com
September 6th 2024

Combining Infrared Spectroscopy, AI May Influence More Reliable Diagnosis of MG

AJMC Contributor
If integrated into clinical practice, the approach could fill a need for more optimal diagnostic approaches for myasthenia gravis (MG), explained the researchers.
managed care cast logo
August 22nd 2024

Obesity Uncovered: Dr Eden Miller on US Obesity Epidemic, Insurance Shortcomings

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the August 2024 issue of The American Journal of Managed Care® that reviews the US obesity epidemic and discusses inadequate obesity management insurance coverage.
heart check with magnifying glass | Image Credit: Atlantist studio-stock.adobe.com
September 6th 2024

ESC 2024: Advancing Care With New Cardiovascular Research

Maggie L. Shaw
At the 2024 European Society of Cardiology Congress (ESC), key research in cardiology care included studies conducted on cardiovascular disease risk among women, cardiac distress and smoking, and lipoprotein(a).
hands of a patient with vitiligo | Image Credit: Rabizo Anatolii - stock.adobe.com
September 5th 2024

Patients With Vitiligo Experience Poorer Quality of Life but Greater Health Care Access, Utilization

Brooke McCormick
Compared with those without vitiligo, patients with vitiligo have higher health care access and utilization but report a lower quality of life.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
CH LogoCenter for Biosimilars Logo